Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predict Postdischarge Survival
- 1 May 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Heart Failure
- Vol. 1 (1), 25-33
- https://doi.org/10.1161/circheartfailure.107.746933
Abstract
Background— Admission measures of renal function (blood urea nitrogen [BUN], estimated glomerular filtration rate [eGFR]) in patients hospitalized for worsening heart failure are predictors of in-hospital outcomes. Less is known about the changes and relationships among these variables and the postdischarge survival rate. Methods and Results— In a retrospective analysis of 949 patients from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure, we investigated the relation between admission values and changes in BUN and eGFR and rate of death by 60 days after discharge. On admission, median eGFR was 51 mL � min −1 � 1.73 m −2 (interquartile range, 37 to 70 mL � min −1 � 1.73 m −2 ), and BUN was 25 mg/dL (interquartile range, 17 to 41 mg/dL). On average, there was a 1.1–mL � min −1 � 1.73 m −2 decrease in eGFR and a 4.7-mg/dL increase in BUN from admission to discharge. By discharge, 12% of patients had a >25% decrease in eGFR, and 39% had a >25% increase in BUN. Although both lower admission eGFR and higher admission BUN were associated with higher risk of death by 60 days after discharge, multivariable-adjusted Cox proportional-hazards analysis showed that BUN was a stronger predictor of death by 60 days than was eGFR (χ 2 , 11.6 and 0.6 for BUN and eGFR, respectively). Independently of admission values, an increase of ≥10 mg/dL in BUN during hospitalization was associated with worse 60-day survival rate: BUN (per 5-mg/dL increase) had a hazard ratio of 1.08 (95% CI, 1.01 to 1.16). Although milrinone treatment led to a minor improvement in renal function by discharge, the 60-day death and readmission rates were similar between the milrinone and placebo groups. Conclusions— A substantial number of patients admitted with heart failure have worsening renal function during hospitalization. Higher admission BUN and increasing BUN during hospitalization, independently of admission values, are associated with a worse survival rate. Use of milrinone in these high-risk patients does not improve outcomes despite minor improvements in the renal function.Keywords
This publication has 31 references indexed in Scilit:
- Relation between dose of loop diuretics and outcomes in a heart failure population: Results of the ESCAPE TrialEuropean Journal of Heart Failure, 2007
- Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH)European Heart Journal, 2006
- Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart FailureCirculation, 2006
- Role of Diminished Renal Function in Cardiovascular MortalityJournal of the American College of Cardiology, 2005
- Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)American Heart Journal, 2005
- Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failureThe American Journal of Cardiology, 2004
- Relationship between heart failure treatment and development of worsening renal function among hospitalized patients11Guest Editor for this manuscript was Peter M. Okin, MD, New York Hosptial-Cornell Medical Center, New York, NY.American Heart Journal, 2004
- Correlates and impact on outcomes of worsening renal function in patients ≥65 years of age with heart failure ∗The American Journal of Cardiology, 2000
- Hormones and Hemodynamics in Heart FailureNew England Journal of Medicine, 1999
- Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: A multicenter studyJournal of the American College of Cardiology, 1987